Dr. Javad Parvizi is an American Board Certified orthopaedic surgeon and the director of clinical research at the Rothman Orthopaedic Institute, Philadelphia.[2] He holds the James Edwards Professor Chair of Orthopaedics at Thomas Jefferson University. He is the co-founder of the International Consensus Meeting and President of the Musculoskeletal Infection Society (MSIS).[3][4]

Javad Parvizi
Alma mater
Awards
Scientific career
Institutions
Website

Early life and education

edit

Parvizi was born in Zanjan, Azerbaijan, Iran in 1965.[5] He lived there until the age of 16.[6]

Dr. Javad Parvizi trained in the United Kingdom, the United States and Switzerland. He earned his medical degree from the University of Sheffield, UK in 1991 and then underwent specialist surgical training in Newcastle, UK. In 1995, he moved to Rochester, US, to the Mayo Clinic as a research fellow and graduate student. In 1997 he obtained a Master of Science in Orthopaedics from the Mayo Foundation, Mayo Clinic, Rochester.[7] He then started the residency in Orthopaedic Surgery at the Mayo Clinic. After finishing the residency in 2002, he was awarded the Hip Society-Muller Foundation Fellowship in Adult Reconstruction to spend additional surgical training at the Insalspital Hospital at the University of Berne, Switzerland. In Berne, he worked with Dr. Maurice Edmond Müller, and Professor Reinhold Ganz to learn joint preservation surgical management of the hip. After his training in Bern, he joined the Rothman Institute in 2003, where he has remained until this date.[8]

Research and career

edit

The most important area of his research is infections following joint replacement and also conducted research on the bacterial free-floating biofilms that form in human joint infections.[9][10] He also did research on the low-dose aspirin, finding it as effective as higher-dose aspirin for the prevention of venous thromboembolism and associated with fewer gastrointestinal side effects.[11]

Dr. Javad Parvizi is a Joint Replacement Surgeon at the Rothman Orthopaedic Speciality Hospital and also serving at the Thomas Jefferson University Hospital as a Vice Chairman of Research.[12] During his tenure at Jefferson Medical College, he served in different positions from Assistant Professor to Professor in the Department of Orthopaedic Surgery. He served as the President of the Eastern Orthopaedic Association in the year 2018.[13][14]

Awards and honors

edit

Dr. Javad Parvizi received the Chitranjan Ranawat Award from the Knee Society.[15] Additional awards include the Mark Coventry Award, Insall Award, ASHP best practice award, Best researcher of the year award, and Otto Aufranc Award.[16][17][18][19][20] He served as one of the board of directors at Maurice. E. Muller Foundation of North America and presented at the 2019 American Association of Hip and Knee Surgeons annual meeting.[21][22]

Patents

edit

Dr. Javad Parvizi has applied for several patents for his inventions. His patent applications include,

  • Materials and methods for diagnosis of peri-implant bone and joint infections using prophenoloxidase pathway, (2017).[23]
  • Methods utilizing D-dimer for diagnosis of periprosthetic joint infection, (2017).[24]
  • Covalent modification of decellularized allogeneic grafts with active pharmaceuticals, (2017).[25]

Books

edit
  • Orthopedic Examination Made Easy. Amazon Books. 2006. ISBN 978-0443100017[26]
  • Operative Techniques in Joint Reconstruction Surgery. 2016. ISBN 978-1451193060[27]
  • High Yield Orthopaedics. Elsevier. 2010. ISBN 978-1416002369[28]
  • Essentials in Total Hip Arthroplasty. Slack Incorporated. 2009. ISBN 978-1556428708[29]
  • Operative Techniques in Adult Reconstruction Surgery. Lippincott Williams and Wilkins. 2010. ISBN 978-1451102628[30]

Grants

edit

Dr. Javad Parvizi's research on musculoskeletal infection was funded by the National Institute of Health (NIH) agency and the project started on 25 September 2013 and it ended on 31st August 2014 and the total cost incurred for this project is $15,000.[31]

Dr. Javad Parvizi's research on smart hip Implants with the modified biological surface was funded by the NIH agency The project started on 1 May 2005 and it ended on 30 March 2010, and the total cost incurred was $87,480.[32]

Publications

edit
  • Javad Parvizi, and Kyung-Hoi Koo. "Should a Urinary Tract Infection Be Treated before a Total Joint Arthroplasty?". Journal of Hip and Pelvis.[33]
  • Javad Parvizi, Thorsten Gehrke, Michael A. Mont, and John J. Callaghan. "Introduction: Proceedings of International Consensus on Orthopedic Infections". The Journal of Arthroplasty.[34]
  • Javad Parvizi, Laurent Sedel, and Michael Dunbar. "Clinical Faceoff: Instability After THA The Potential Role of the Bearing Surface". Journal of Clinical Orthopaedics and Related Research.[35]
  • Javad Parvizi, Jessica R Benson, and Jeffrey M Muir. "A new mini-navigation tool allows accurate component placement during anterior total hip arthroplasty". Journal of Dovepress.[36]
  • Javad Parvizi, Timothy L.Tan, Karan Goswami, Carlos Higuera, Craig Della Valle, Antonia F.Chen, and Noam Shohat. "The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated Criteria". The Journal of Arthroplasty.[37]

References

edit
  1. ^ "Chitranjan Singh Ranawat Award". www.beckersspine.com. 18 February 2013.
  2. ^ "Javad Parvizi, M.D." rothmanortho.com. Retrieved 22 January 2020.
  3. ^ 2018 International Consensus Meeting for Periprosthetic Joint Infection, retrieved 22 January 2020
  4. ^ "Executive Board Members | Musculoskeletal Infection Society – MSIS". www.msis-na.org. Retrieved 22 January 2020.[permanent dead link]
  5. ^ Parvazi, Javad. "American Dream: the story of an immigrant" (PDF). OrthoBullets.
  6. ^ "Javad Parvizi" (PDF). Scientific Advisory Board - Bezmialem Vakıf Üniversitesi.
  7. ^ "Parvizi, Javad - Philadelphia University + Thomas Jefferson University - Thomas Jefferson University". www.jefferson.edu. Retrieved 22 January 2020.
  8. ^ "Javad Parvizi". www.hamad.qa. Retrieved 22 January 2020.
  9. ^ Yazdi, Hamidreza; Klement, Mitchell R.; Hammad, Mohammed; Inoue, Daisuke; Xu, Chi; Goswami, Karan; Parvizi, Javad (22 October 2019). "Tranexamic Acid Is Associated With Reduced Periprosthetic Joint Infection After Primary Total Joint Arthroplasty". The Journal of Arthroplasty. 35 (3): 840–844. doi:10.1016/j.arth.2019.10.029. ISSN 0883-5403. PMID 31722855. S2CID 208019644.
  10. ^ Gilbertie, Jessica M.; Schnabel, Lauren V.; Hickok, Noreen J.; Jacob, Megan E.; Conlon, Brian P.; Shapiro, Irving M.; Parvizi, Javad; Schaer, Thomas P. (15 August 2019). "Equine or porcine synovial fluid as a novel ex vivo model for the study of bacterial free-floating biofilms that form in human joint infections". PLOS ONE. 14 (8): e0221012. Bibcode:2019PLoSO..1421012G. doi:10.1371/journal.pone.0221012. ISSN 1932-6203. PMC 6695105. PMID 31415623.
  11. ^ "ovid.com". insights.ovid.com. Retrieved 22 January 2020.
  12. ^ "Javad Parvizi, MD - Jefferson University Hospitals". hospitals.jefferson.edu. Retrieved 22 January 2020.
  13. ^ "Javad Parvizi". www.hamad.qa. Retrieved 22 January 2020.
  14. ^ "eoa-assn.org" (PDF).
  15. ^ Vaidya, Anuja (18 February 2013). "Knee Society Honors 6 Orthopedic Surgeons With Chitranjan Ranawat Award". www.beckersspine.com. Retrieved 22 January 2020.
  16. ^ Dyrda, Laura. "Rothman Institute's Dr. Javad Parvizi Earns Research Award". www.beckersspine.com. Retrieved 22 January 2020.
  17. ^ "FARE | AAHKS". www.aahks.org. 7 February 2019. Retrieved 22 January 2020.
  18. ^ "Past Recipients - ASHP". www.ashp.org. Retrieved 22 January 2020.
  19. ^ "Editorial Board – Reduce Revisions". www.reducerevisions.org. Archived from the original on 11 August 2020. Retrieved 22 January 2020.
  20. ^ "hipsoc.org" (PDF).[permanent dead link]
  21. ^ "memfna.org".[permanent dead link]
  22. ^ "Presenters – Javad Parvizi, MD, FRCS – Annual Meeting". meeting.aahks.net. Retrieved 22 January 2020.
  23. ^ US application 2017045532, Parvizi, Javad & Alijanipour, Pouya, "Materials and methods for diagnosis of peri-implant bone and joint infections using prophenoloxidase pathway", published 2017-02-16 
  24. ^ WO application 2017151794, Shahi, Alisina & Parvizi, Javad, "Methods utilizing D-dimer for diagnosis of periprosthetic joint infection", published 2017-09-08, assigned to Rowan University 
  25. ^ WO 2017059418, Ketonis, Constantinos; Hickok, Noreen J. & Parvizi, Javad et al., "Covalent modification of decellularized allogeneic grafts with active pharmaceuticals", published 2017-04-06, assigned to Thomas Jefferson University 
  26. ^ Parvizi, Javad. (2006). Orthopaedic examination made easy. Edinburgh: Churchill Livingstone. ISBN 0-443-10001-2. OCLC 62302597.
  27. ^ Operative techniques in joint reconstruction surgery. Parvizi, Javad,, Rothman, Richard H., 1936-, Wiesel, Sam W. (Second ed.). Philadelphia. August 2015. ISBN 978-1-4511-9306-0. OCLC 925784958.{{cite book}}: CS1 maint: location missing publisher (link) CS1 maint: others (link)
  28. ^ Parvizi, Javad. (19 July 2010). High yield orthopaedics. Kim, Gregory K. (1st ed.). Philadelphia. ISBN 978-1-4377-3629-8. OCLC 698080054.{{cite book}}: CS1 maint: location missing publisher (link)
  29. ^ Parvizi, Javad. Essentials in total hip arthroplasty. Klatt, Brian A.,, Adams, Christopher S. Thorofare, New Jersey. ISBN 978-1-63091-018-1. OCLC 878145937.
  30. ^ Operative techniques in adult reconstruction surgery. Parvizi, Javad., Rothman, Richard H., 1936-, Wiesel, Sam W. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins. 2011. ISBN 978-1-4511-0262-8. OCLC 649827237.{{cite book}}: CS1 maint: others (link)
  31. ^ Parvizi, Javad. "AAOS Musculoskeletal Infection: Where are we in 2014? Research Symposium".
  32. ^ Parvizi, Javad. "Smart Hip Implants with Modified Biological Surface".
  33. ^ Parvizi, Javad; Koo, Kyung-Hoi (2019). "Should a Urinary Tract Infection Be Treated before a Total Joint Arthroplasty?". Hip & Pelvis. 31 (1): 1–3. doi:10.5371/hp.2019.31.1.1. ISSN 2287-3260. PMC 6414408. PMID 30899708.
  34. ^ Parvizi, Javad; Gehrke, Thorsten; Mont, Michael A.; Callaghan, John J. (1 February 2019). "Introduction: Proceedings of International Consensus on Orthopedic Infections". The Journal of Arthroplasty. 34 (2): S1–S2. doi:10.1016/j.arth.2018.09.038. ISSN 0883-5403. PMID 30343969. S2CID 53044000.
  35. ^ Parvizi, Javad; Sedel, Laurent; Dunbar, Michael J. (April 2018). "Clinical Faceoff: Instability After THA". Clinical Orthopaedics and Related Research. 476 (4): 678–683. doi:10.1007/s11999.0000000000000162. ISSN 0009-921X. PMC 6260073. PMID 29543657.
  36. ^ Parvizi, Javad; Benson, Jessica R.; Muir, Jeffrey M. (22 March 2018). "A new mini-navigation tool allows accurate component placement during anterior total hip arthroplasty". Medical Devices: Evidence and Research. 11: 95–104. doi:10.2147/mder.s151835. PMC 5868583. PMID 29606894.
  37. ^ Parvizi, Javad; Tan, Timothy L.; Goswami, Karan; Higuera, Carlos; Valle, Craig Della; Chen, Antonia F.; Shohat, Noam (1 May 2018). "The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated Criteria". The Journal of Arthroplasty. 33 (5): 1309–1314.e2. doi:10.1016/j.arth.2018.02.078. ISSN 0883-5403. PMID 29551303.
edit